18MM

Amundi Index MSCI Pacific Ex Japen SRI PAB - UCITS ETF DR - EUR C

ETFs & Funds · EUR · XETRA

18MMETFT212

Price

€636.2

-0.52%

Cap

Earnings

30d Trend

-1.9%

18MM
Loading chart data...
0 days · % change from startPowered by Brain47
VolatilityLow

16% annualised over 90 days

BRAIN47 SIGNAL

0
STRONG
Risk Level25
Momentum57
Technical49
Fund Quality75
Cost Efficiency74

Raw weighted: 66×Macro 0.99 (1%)=65

RISK

25/100
90d Volatility
16.0%Low
ATR %
1.0%Low daily moves
Max Drawdown (1Y)
-6.5%Resilient

MOMENTUM

57/100
12-1M Momentum
+4.9%Uptrend
6-1M Momentum
+3.6%Flat
1M Return
-1.4%Stable

TECHNICAL

49/100
RSI (14)
40.3Neutral
Price vs SMA200
+0.4%Flat
MACD
-1.77Bearish momentum
Bollinger Band
6%Near lower band
SMA Cross
Death CrossDeath Cross
Trend Quality (KER)
0.082Noisy/choppy

FUND QUALITY

75/100
Replication
PhysicalHolds actual assets
Holdings
137 positionsWell diversified
Domicile
Ireland (tax-efficient)15% US withholding tax

COST EFFICIENCY

74/100
Expense Ratio
0.20%Low cost
Fund Size (AUM)
$861MSmall
Tracking Difference
-0.04%Excellent tracking

Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 100%

Running historical backtest...

BRAIN47 HORIZON ANALYSIS

<3 months38
3-12 months55
1-5+ years68

Long-term compounder — quality business with growth runway

BRAIN47'S ASSESSMENT

I rate Amundi Index MSCI Pacific Ex Japen SRI PAB - UCITS ETF DR - EUR C at 65/100 — a STRONG reading on the Brain47 Signal. The strongest factor is risk management at 75/100. I classify this as a defensive position with the strongest thesis on a long-term horizon.

PAST PERFORMANCE

1 MONTH

-1.4%

3 MONTHS

-4.1%

12 MONTHS

+3.5%

Trailing returns — past performance, not a projection.

DETAILED ANALYSIS

Long-term compounder — quality business with growth runway. low-risk profile and Fund Quality (75) are the primary strengths. Historical volatility is normal at 16%. I classify this as a defensive holding — low volatility and high business quality provide portfolio ballast.

defensiveScore: 65/100

Want full analysis on every stock?

Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.

Join Brain47 — Free

Generated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.